World Health Organization, Coronavirus, Covıd-19

World Health Organization, Coronavirus

WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death

WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death

5/7/2020 1:27:00 AM

WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death

The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination ...

BookmarkGENEVA: The World Health Organization (WHO) said on Saturday (Jul 4) that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality.

Singapore's COVID-19 cases cross 55,000 mark, with 175 new infections North Korea brings aid supplies to border town under COVID-19 lockdown: State media NDP 2020: Healthcare workers saluted as National Day Parade comes to the heartlands

The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day. The United States accounted for 53,213 of the total 212,326 new cases recorded on Friday, the WHO said.AdvertisementAdvertisement

"These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalised COVID-19 patients when compared to standard of care."Solidarity trial investigators will interrupt the trials with immediate effect," the WHO said in a statement, referring to large multi-country trials that the agency is leading.

The UN agency said that the decision, taken on the recommendation of the trial's international steering committee, does not affect other studies where the drugs are used for non-hospitalised patients or as a prophylaxis.Another branch of the WHO-led trial is looking at the potential effect of Gilead's antiviral drug remdesivir on COVID-19. The European Commission on Friday gave remdesivir conditional approval for use after being shown to shorten hospital recovery times.

AdvertisementAdvertisementThe solidarity trial started out with five branches looking at possible treatment approaches to COVID-19: standard care; remdesivir; hydroxychloroquine; lopinavir/ritonavir; and lopanivir/ritonavir combined with interferon.WHO director-general Tedros Adhanom Ghebreyesus told reporters on Friday that nearly 5,500 patients in 39 countries had been recruited so far into its clinical trials and that interim results were expected within two weeks.

Some 18 experimental COVID-19 vaccines are being tested on humans among nearly 150 treatments under development. Read more: CNA »

WHO halts hydroxychloroquine, HIV drugs in Covid-19 trials after failure to reduce deathGENEVA (REUTERS) - The World Health Organisation (WHO) said on Saturday (July 4) that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with Covid-19 after they failed to reduce mortality.. Read more at straitstimes.com.

WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce deathThe World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination ...

WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce deathThe World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination ...

WHO halts hydroxychloroquine, HIV drugs in Covid-19 trials after failure to reduce deathGENEVA (REUTERS) - The World Health Organisation (WHO) said on Saturday (July 4) that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with Covid-19 after they failed to reduce mortality.. Read more at straitstimes.com.

COVID-19: WHO expects first results from drug trials within two weeksGENEVA: The World Health Organization (WHO) should soon get results from clinical trials it is conducting of drugs that might be effective in ...

COVID-19 vaccines to enter late-stage trial by end of July: Fauci COVID-19 vaccine candidates will enter late-stage clinical studies by the end of the month, with others beginning in August, September and ...